




版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
TheBasicsandRecentDevelopmentsinUSPatentPracticeAlanS.Nadel,Esq.,PartnerWeihongHsing,Ph.D.,Esq.IntellectualProperty(IP)EverythingyoudevelopcanbeyourIPThreewaysto“handle”IPPublish:makeitfreelyavailabletothepublicTradeSecret:“hide”fromthepublic,butprotectbyagreements,risklossofexclusivityifmadepublicPatent:agovernmentgrantedexclusiverightgivenforalimitedamountoftimeinexchangeforcompletedisclosureoftheinvention
ExclusiveRightInventorshaverighttoexcludeothersfrommaking,selling,offeringtosell,using,orimportingtheinventionintheU.S.Righttoexclude
righttopracticeWaystouseapatentAssignmentinexchangeforincome:completelytransferstherighttoexcludeLicenseinexchangeforincome:partiallytransferstherighttoexcludePatentlitigationMaintainrighttoexclude:seekinjunctionCompensation:seeklostprofitsandreasonableroyaltyPatenttermillustrationJune8,1995Filed3/18/942NDfiled3/10/961STfiled3/18/94Filed3/18/96Filed3/18/94Issued3/30/00Issued3/30/98Issued6/7/95Expires3/30/15,thelongertermof17yfromissuanceor20yfromfiling
Expires3/18/14,thelongertermof17yfromissuanceor20yfromfiling
Expires3/18/16,20yfromfiling
Issued3/25/00Expires3/18/14,20yfrom1stfilingCompletedisclosure(35U.S.C.§112)
Enablement
mustteachoneskilledinthearthowtomakeandusetheclaimedinventionwithoutundueexperimentationChemicalorbiotechinventionisconsideredunpredictable,it’softennotsufficientby,e.g.,propheticexamplesonlywithoutdataoractualexamples;1or2speciesforagenusclaim.
Sufficientwrittendescription
suchthatoneskilledintheartreadingthedescriptionwouldrecognizethattheinventorhadinventedtheclaimedsubjectmatterandhadpossessionoftheinventionatthetimetheapplicationwasfiledClaim
definiteness
mustparticularlypointoutanddistinctlyclaimthesubjectmatterwhichtheinventorregardsasherinventionDefinesthemetesandboundsoftheinventionMustincludeallessentialelementsoftheinventionBest
Mode
knowntotheinventorattimeatthetimetheapplicationwas
filed.
Whatcanbepatented?
“Anythingunderthesunthatismadeby[hu]man”Designpatent:new,originalandornamentaldesignPlantpatent:asexuallyreproduced,nottuber-propagating,cultivatedplantUtilitypatent:machine,manufacture,process,compositionorimprovement,e.g.,Isolatednucleicacids,proteins,cells,antibodiesTransgeniccells,animals,plantsBiomarker,crystalstructure,deviceMethodsoftreatment,diagnosis,synthesis,storageCompoundsandnovelintermediatesProcessincludesnewuseofoldmaterial Whatcannotbepatented?(35U.S.C.§101)
NaturallyoccurringUnlesspurifiedorgeneticallyengineeredScientificprincipleUnlessusedinprocessorapparatusLackutilityforutilitypatentFraudulentutility,i.e.,transgenicanimalassnakefood;acandlelightforburglarInoperative,i.e.,perpetualmotionNot“realworld”use,i.e.,useESTasaprobeSubjecttoU.S.DeptofDefensereviewi.e.,AtomicBombsNonobviousRequirement
(35U.S.C.§103)
Iftwoormorepublicationscanbecombinedtodiscloseallelementsofaclaimedinvention,theymayrendertheclaimedinventionobvious
RecentU.S.SupremeCourtcasemaymakeiteasiertofindaclaimedinventionobvious,KSRv.Teleflex
Inordertorenderaclaimobvious,thepriorartpublicationsneednotexplicitlycontainteaching/suggestion/motivationthatwouldleadoneofordinaryskillinthearttocombinethepriorartinthemannerasclaimed;obvioustotrymaysuggestobvious.USPTOKSRMemo:itremainsnecessarytoidentifythereasonwhyapersonofordinaryskillintheartwouldhavecombinedthepriorartelementsinthemannerclaimedKSRreaffirmedthefourfactortestunderGrahamv.JohnDeere
Thescopeandcontentofthepriorart;Thedifferencebetweentheclaimsatissueandpriorart;Thelevelofordinaryskillinpertinentart;andEvidenceofsecondaryconsiderations(objectivecriteria):commercialsuccess;longfeltbutunsolvedneeds;failureofothers;recognitionofproblem;unexpectedresults;copyingbyothers,etc.ProvisionalapplicationEffectivesinceJune8,1995byU.S.PTOSimplifyfiling,lowcost,1extrayearof“patentpending”.NoStartingpatentterm,examination,amendment,publication,claim,oath/declaration,andIDS.YesPrioritydate,completewrittendisclosure,namingatleast1inventor,filingfee,identificationasaprovisionalfiling.Toclaimthebenefitofearlierprioritydatefromaprovisionalapplication,thenon-provisionalmustbefiledwithin1yfromprovisionalfilingdate(F.D.)musthavesupportinprovisionalmayclaimbenefitofmorethan1provisionalmayaddnewmatter(withoutthebenefitofpriority)Automaticallybecomesabandoned1yafteritsF.D.InterferenceAlegalprocessbyUSPTOtodeterminewhoisthefirsttoinventtheinventionattheclaimedscope.Canbedeclaredbetweentwopatentapplicationsorapatentapplicationandapatentissuedlessthanoneyearfromthefilingdateofthepatentapplication.U.S.firsttoinvent,mostothersfirsttofile.(MaychangeinproposedlawpendinginCongress)Proofoffirsttoinvent:notebookNotebookentriessufficientlydemonstratethattheinventorhasformedadefiniteandpermanentideaofthecompleteandoperableinventionWhattoinclude: -Ideasandspeculationsasdocumentationofconception
-FACTS
-Conditionsinwhichinventionistestedandisshowntowork
WhatNOTtoinclude:
Speculationsorconclusionsincludingnotesoropinionson:
-Patentability
-Priorart
-Whetheracomponentiscriticaloressentialtothe inventionShouldbehardcopy(orinatangiblemedium),signed,dated,andwitnessedbyathirdpartyRecordkeeping:Emails,Drafts,NotebooksEverythingyouwrotecanbeusedagainstyouinacourtNoDiscussionofpatentabilityinemailCommentsonpriorartUse“extreme”terms,e.g.,key,critical,essential,required,alwaysKeepingmanyversionsofolddraftsNotebookentriesinpencil(usepen)LooseslipsofpapertorecorddataErasures,blankorpartialblankpagesinnotebookNotsignanddateandwitnesseachpageofthenotebookUsepasttensetodescribeexperimentsthathavenotbeendoneDescriptioninnotebooknotsufficienttoenableanotherpersontoduplicatetheprocedureandresultsHideornotinformpatentattorneyofrelevantpriorartreferencesWhocanbeaninventor?Apersonwhocontributesto
theconceptof
issued
claimsfortheinventionContributiontotheconceptmustbecomplete,operableNottheonewhohadthemereideaw/ospecificplansonhowtorealizetheidea
Contributionmustbe>exerciseofordinaryskilloftheartNottheonewhomerelyfollowedinstructionsandmadetheinventionInventorshipmayvaryfromclaimtoclaimInventorshipmaychangeduringprosecutionTheorderhasnolegalsignificanceInventorship≠authorshipWronginventorshiprenderspatentunenforceableCanbecorrectedifoccurredwithoutdeceptiveintentThecorrectnessofinventorshipisonlyexaminedduringinterferenceorlitigationNotebook,writtendocumentationWhathappenstoapatentapplication?PrioritydateUSnon-prov’lPCTapp’n(Havenewdataready2mbefore)1YearUSprov’lorOtherforeignfilingforprioritydate30(or31)MonthFileNat’lorRegionalapp’nsbasedonPCTapp’nBegin20Year-termPublicationUSnon-prov’lPCTapp’n1Year0.5YearIssuanceorabandonedPatentExaminationIttakesabout3-5yearsfromthefirstF.D.totheissuanceofabiotechpatent.OfficeActionsfromapatentexamineroftheUSPTORestrictionrequirementrequiringanelectionbetweentwoormoreindependentorpatentablydistinctinventionsToensurethatthefeespaidforexaminationarecommensuratewiththescopeoftheexaminationRejections101:lackutility102:notnoveltyinviewofonepriorartreference103:obviousinviewofthecombinationofmultiplepriorart112:notenabled,lackwrittendescription,indefiniteObjectionsformality,spellingerrors,etc.ResponsestoanOfficeActionfromtheinventorMustelectaninventionforexaminationinresponsetoarestrictionrequirement,evenifdisagreewiththerestrictionrequirementMustaddresseachrejectionandobjectionandbeabonafideattempttoadvanceexaminationCanamendclaimsandspecification,butcannotaddnewmatterMustbefiledwithinlimitedtimeperiod,6monthmax.withextensionfeesMaysubmitnewdatatosupportenablementbydeclarationHowtoreadapatent/publication?
Claims:definewhatthepatentorapp’ncoversDetaileddescriptionInventors/Assignee(Assigneeneednotbelistedonpatentorpublishedpatentapp’n)PatenttermPrioritydateRelevantcitationsAnisolatedandpurifiedpolypeptidecomprisingthe
sequenceofaminoacids215to477ofSEQIDNO:2.
Theisolatedandpurifiedpolypeptideaccordingtoclaim1,consistingofthesequenceofaminoacids215to477ofSEQIDNO:2.
Whatisclaimedis:HowtoreadclaimsClaim1:anindependentclaimhavingbroadscopeClaim2:adependentclaimhavingnarrowerscopeTransitionalphrasesusedinclaimsOpen-ended:includingbutnotlimitedtoadditional,unrecitedelementsorsteps“Comprising”Closed:limitstheclaimtospecifiedelementsorsteps“Consistingof”Partiallyclosed:includesthosethatdonotmateriallyaffectthebasicandnovelcharacteristicsoftheclaim“consistingessentiallyof”RecentPatentCasesfromU.S.SupremeCourtSincetheFederalCircuit(CAFC)wascreatedin1982,theU.S.SupremeCourthastakenveryfewpatentcases,leavingtheFederalCircuittohavethefinalauthorityonpatentlawHowever,since1999,theSupremeCourthastaken9patentcases,andreversedtheFederalCircuitinmostofthemRecently,theSupremeCourthastakenfourpatentcases:EBay,Inc.v.MercExchangeInc.126S.Ct.1837(2006)MedImmuneInc.v.GenentechInc.127S.Ct.764(2007)KSRInternationalCo.v.TeleflexInc.etal.,April30,2007MicrosoftCorp.v.AT&TCorp.,April30,2007EBay,Inc.v.MercExchangeInc.
(permanentinjunctionsagainstpatentinfringement)TheFederalCircuit(CAFC)“generalrule”:courtswouldissuepermanentinjunctionsagainstpatentinfringementabsentexceptionalcircumstances.”U.S.SupremeCourtvacatedCAFC’sdecisionagainsteBayputtinganendtotheCAFC’s“generalrule”traditional“four-factortest”fordeterminingwhethertoissueapermanentinjunctionapplieswithequalforcetopatentdisputes.Apatentholdermustdemonstrate:(1)thatithassufferedanirreparableinjury;(2)thatremediesavailableatlaw,suchasmonetarydamages,areinadequatetocompensateforthatinjury;(3)that,consideringthebalanceofhardshipsbetweentheplaintiffanddefendant,aremedyinequityiswarranted;and(4)thatthepublicinterestwouldnotbedisservedbyapermanentinjunction.Thedecisionmayaffectpatentenforceabilitybymakinganinjunctionhardertoobtainforapatentholder.MedImmuneInc.v.GenentechInc
(jurisdictionforadeclaratoryjudgmentactionbyalicensee)
CAFCalicenseewhohadcompliedwiththetermsofitslicenseagreementcannotbringadeclaratoryjudgmentactiontochallengethevalidityofapatent,becausethereisnocauseofactualcontroversy,i.e.,possibilityofinfringementsuitorlicensecancellationbylicensorSupremeCourtapersonthathasbeenlicensedtouseapatentneednotbreakthatagreementbeforesuingtochallengethepatent'svalidityordefendagainstaclaimofinfringementMaymakeiteasiertobringasuittochallengethevalidityofapatentbyDeclaratoryJudgment.KSRInternationalCo.v.TeleflexInc.
(testforobviousness)CAFCrigidtest:requiredsometeaching/suggestion/motivation(TSM)inthepriorartpublicationsthatwouldleadoneofordinaryskillinthearttocombinethepriorartinthemannerasclaimedbeforeholdingtheclaimobviousSupremeCourtrejectedCAFC’srigidtestthemoreflexibletestunderKSR:thepriorartmaynotexplicitlycontainTSM;andobvioustotrymaysuggestobvious.reaffirmedthefourfactortestunderGrahamv.JohnDeere
Thescopeandcontentofthepriorart;Thedifferencebetweentheclaimsatissueandpriorart;Thelevelofordinaryskillinpertinentart;andEvidenceofsecondaryconsiderations:commercialsuccess;longfeltb
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 縫制設(shè)備遠(yuǎn)程診斷與維護(hù)服務(wù)考核試卷
- 旅行社團(tuán)隊(duì)建設(shè)與管理考核試卷
- 電氣機(jī)械的設(shè)計(jì)參數(shù)與選型指南考核試卷
- 自動(dòng)扶梯梯級(jí)防滑與防夾技術(shù)的智能化實(shí)現(xiàn)與案例分析考核試卷
- 疫苗接種在應(yīng)對(duì)全球抗生素耐藥性危機(jī)中的地位考核試卷
- 建筑物拆除工程監(jiān)理考核試卷
- 軌道維護(hù)與修復(fù)設(shè)備考核試卷
- 股權(quán)代持與公司財(cái)務(wù)狀況監(jiān)管協(xié)議
- 藥品安全消防管理
- 教育行業(yè)教學(xué)資源共享及培訓(xùn)合作框架協(xié)議
- ISO15614-1 2017 金屬材料焊接工藝規(guī)程及評(píng)定(中文版)
- MOOC 一生的健康鍛煉-西南交通大學(xué) 中國(guó)大學(xué)慕課答案
- 《中國(guó)潰瘍性結(jié)腸炎診治指南(2023年)》解讀
- 宣傳費(fèi)用結(jié)算合同
- 護(hù)理文獻(xiàn)分享的課件
- 重慶十八中學(xué)2024屆八年級(jí)下冊(cè)數(shù)學(xué)期末教學(xué)質(zhì)量檢測(cè)試題含解析
- 企業(yè)周年慶蛋糕定制協(xié)議
- 林業(yè)創(chuàng)業(yè)計(jì)劃書
- 量子計(jì)算芯片技術(shù)
- 電子元件考題及參考答案
- 國(guó)家開(kāi)放大學(xué)(中央電大)報(bào)名登記表(附填寫說(shuō)明)
評(píng)論
0/150
提交評(píng)論